Physician profile
Deval Patel
NPI 1962839340
$7,275.39
in general payments reported to CMS, 2019-2025
35 companies · $1,373 in 2025
The $1,373 reported for 2025 was more than what 90% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,257 · 2022: $1,215 · 2023: $1,533 · 2024: $1,898 · 2025: $1,373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,803.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $901.69 | 2021-2025 | Wegovy, Ozempic |
| Glaxosmithkline, LLC. | $708.43 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $664.36 | 2021-2025 | Evenity, Prolia, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $644.36 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $530.05 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $502.73 | 2021-2025 | Jardiance |
| Abbvie INC. | $395.58 | 2021-2025 | |
| Lilly USA, LLC | $385.50 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $346.77 | 2023-2025 | Freestyle Libre 3, Proclaim, Freestyle Libre 2 |
| Exact Sciences Corporation | $260.42 | 2023-2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $245.75 | 2023-2025 | |
| Shield Therapeutics INC | $229.35 | 2023-2025 | Accrufer |
| Sanofi-Aventis U.S. LLC | $189.84 | 2021-2023 | |
| Dexcom, INC. | $173.60 | 2023-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $151.99 | 2024-2025 | Voquezna |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $145.17 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $139.24 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $125.81 | 2021-2024 | Gardasil 9, Capvaxive, Gardasil |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $119.30 | 2023-2025 | Xifaxan, Trulance, Cycloset |
| Biohaven Pharmaceutical Holding Company LTD. | $77.37 | 2022 | |
| Astellas Pharma US INC | $53.56 | 2024 | Veozah |
| Clarus Therapeutics INC. | $43.35 | 2021 | |
| Seqirus USA INC | $36.90 | 2023-2024 | Flucelvax, Fluad, Fluad Quadrivalent |
| Insulet Corporation | $28.32 | 2025 | Omnipod |
| Alexion Pharmaceuticals, INC. | $21.45 | 2021 | |
| Sanofi Pasteur INC. | $19.67 | 2022 | |
| Stryker Corporation | $19.29 | 2021 | |
| Amarin Pharma, INC. | $19.04 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $17.02 | 2024 | Eliquis |
| Biohaven Pharmaceuticals, INC. | $15.90 | 2021 | |
| Cequr Corporation | $15.83 | 2024 | Cequr Simplicity |
| Kowa Pharmaceuticals America, INC. | $14.53 | 2022 | |
| Medtronic, INC. | $14.04 | 2025 | Minimed 780g |
| Endogastric Solutions, INC | $12.66 | 2024 | Esophyx |
| Genentech USA, INC. | $6.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deval Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.